Chemically engineering the drug release rate of a PEG-paclitaxel conjugate using click and steric hindrance chemistries for optimal efficacy-Reference-Cited by-同舟云学术

Chemically engineering the drug release rate of a PEG-paclitaxel conjugate using click and steric hindrance chemistries for optimal efficacy

Published:2022-10 Issue: Volume:289 Page:121735
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Nguyen Anne,Chao Po-Han,Ong Chun Yat^ORCID,Rouhollahi Elham,Fayez Nojoud AL,Lin Louis,Brown Jennifer I.,Böttger Roland^ORCID,Page Brent^ORCID,Wong Harvey,Li Shyh-Dar^ORCID

Funder

Natural Sciences and Engineering Research Council of Canada

Canada Foundation for Innovation

Deutsche Forschungsgemeinschaft

University of British Columbia

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference40 articles.

1. Recent trends in bioresponsive linker technologies of Prodrug-Based Self-Assembling nanomaterials;Nguyen;Biomaterials,2021

2. Tuning the efficacy of esterase-activatable prodrug nanoparticles for the treatment of colorectal malignancies;Wang;Biomaterials,2021

3. The effect of molecular structure on the anticancer drug release rate from prodrug nanoparticles;Ikuta;Chem. Commun.,2015

4. Ester bonds in prodrugs;Lavis;ACS Chem. Biol.,2008

5. A review of drug release mechanisms from nanocarrier systems;Ding;Mater. Sci. Eng. C,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QbD-based formulation development of resveratrol nanocrystal incorporated into soluble mesoporous material: Pharmacokinetic proof of concept study;International Journal of Pharmaceutics;2024-08

2. Design, synthesis and biological evaluation of novel dihydroquinolin-4(1H)-one derivatives as novel tubulin polymerization inhibitors;European Journal of Medicinal Chemistry;2023-12

3. Prodrug approaches for the development of a long-acting drug delivery systems;Advanced Drug Delivery Reviews;2023-07